Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121982642 | 12198264 | 2 | F | 20070323 | 20160721 | 20160322 | 20160830 | PER | US-JNJFOC-20160217326 | JANSSEN | 10.79 | YR | C | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121982642 | 12198264 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.25 TO 1 MG | Y | U | 0 | TABLETS | |||||||
| 121982642 | 12198264 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1 MG TO 2 MG | Y | U | 0 | TABLETS | |||||||
| 121982642 | 12198264 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1 MG TO 2 MG | Y | U | 0 | TABLETS | |||||||
| 121982642 | 12198264 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1 MG TO 2 MG | Y | U | 0 | TABLETS | |||||||
| 121982642 | 12198264 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 1 MG TO 2 MG | Y | U | 0 | TABLETS | |||||||
| 121982642 | 12198264 | 6 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.25 TO 1 MG | Y | U | 20272 | TABLETS | |||||||
| 121982642 | 12198264 | 7 | SS | RISPERDAL M-TAB | RISPERIDONE | 1 | Oral | U | U | 21444 | TABLETS | ||||||||
| 121982642 | 12198264 | 8 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | U | 0 | UNSPECIFIED | ||||||||
| 121982642 | 12198264 | 9 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | U | 20272 | 2 | MG | UNSPECIFIED | ||||||
| 121982642 | 12198264 | 10 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121982642 | 12198264 | 1 | Aggression |
| 121982642 | 12198264 | 2 | Aggression |
| 121982642 | 12198264 | 3 | Aggression |
| 121982642 | 12198264 | 4 | Attention deficit/hyperactivity disorder |
| 121982642 | 12198264 | 5 | Attention deficit/hyperactivity disorder |
| 121982642 | 12198264 | 6 | Attention deficit/hyperactivity disorder |
| 121982642 | 12198264 | 7 | Product used for unknown indication |
| 121982642 | 12198264 | 8 | Attention deficit/hyperactivity disorder |
| 121982642 | 12198264 | 9 | Attention deficit/hyperactivity disorder |
| 121982642 | 12198264 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121982642 | 12198264 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121982642 | 12198264 | Emotional distress | |
| 121982642 | 12198264 | Gynaecomastia | |
| 121982642 | 12198264 | Off label use | |
| 121982642 | 12198264 | Product use issue | |
| 121982642 | 12198264 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121982642 | 12198264 | 1 | 20070323 | 200709 | 0 | |
| 121982642 | 12198264 | 2 | 201206 | 201306 | 0 | |
| 121982642 | 12198264 | 3 | 200804 | 200905 | 0 | |
| 121982642 | 12198264 | 4 | 200804 | 200905 | 0 | |
| 121982642 | 12198264 | 5 | 201206 | 201306 | 0 | |
| 121982642 | 12198264 | 6 | 20070323 | 200709 | 0 | |
| 121982642 | 12198264 | 8 | 200703 | 200906 | 0 | |
| 121982642 | 12198264 | 9 | 20110926 | 20131111 | 0 |